Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Phase 3 trial launches to study IMVT-1402 in MG

  A new Phase 3 clinical trial is underway to evaluate the efficacy and safety of IMVT-1402, a FcRn inhibitor, in patients with MG.

• New tool developed to help identify patients at risk of myasthenic crisis

  A toll that incorporates clinical variables available to nursing staff could help identify patients at risk of myasthenic crisis.

• Argenx announces positive results from study of efgartigimod for seronegative MG

  Efgartigimod, a therapy approved for anti-AChR-positive MG, has shown promising results in seronegative patients as well.

• Study suggests COVID-19 vaccination benefits patients with myasthenia gravis

  COVID-19 vaccination appears to be safe for those with myasthenia gravis and is associated with reduced infection and hospitalization rates.

• Gefurulimab associated with symptomatic MG improvement

  Results from a clinical trial suggest that treatment with gefurulimab leads to improvement in activities of daily living in adults with MG.

• Study reveals new insights into the implications of thymectomy in MG

  Thymus removal surgery (thymectomy), a therapeutic alternative for MG, appears to have long-lasting consequences for immune system function.

• Study: Women with MG report more severe symptoms than men

  In a recent study, women with myasthenia gravis reported experiencing more severe symptoms and greater rehabilitation needs than men.